Use of medications and pharmaceutical monitoring in the treatment of patients with fibromyalgia
DOI:
https://doi.org/10.33448/rsd-v10i16.23355Keywords:
Fibromyalgia; Pain; Drug Combinations; Drug therapy.Abstract
This research aims to understand how pharmaceutical follow-up can help in the treatment of fibromyalgia, taking into account the main types of drug treatments and the role of the pharmacist. This is an integrative review, where data collection was performed with articles between 2016 to 2021 in the following databases: Latin American and Caribbean Literature on Health Sciences (LILACS), Publisher Medline (PUBMED), Scientific Electronic Library Online (SciELO), using the following descriptors and keywords: Fibromyalgia, Pain, Medicines and Treatment. Through the results obtained, it was found that the best option for the treatment of fibromyalgia is the combination of pharmacological and non-pharmacological interventions, with an emphasis on combined treatments with drugs aimed at multiple molecular mechanisms, as predicted by the Federal Council of Pharmacy. Through the data discussed, it can be concluded that the combination of psychological and physical therapy and the use of drugs is the best option for the treatment of patients with fibromyalgia. In this sense, pharmacology contributes with medications with the purpose of reaching the central pain pathways, favoring the patient and reducing their daily affliction. However, even so, further research is needed on treatment alternatives for this complex condition.
References
Ammad, N. (2018). Comparative Efficacy of Pharmacological and Nonpharmacological Interventions in Managing Primary and Secondary Outcomes of Fibromyalgia Syndrome. Medical Student Research Journal,6 (1), 11-20.
Azevedo, P. M. (2018). A ciência da dor: Sobre fibromialgia e outras síndromes dolorosas persistentes e sobre a natureza humana. São Paulo: Editora Unesp Digital.
Benlidayi, I. C. (2019). Role of inflammation in the pathogenesis and treatment of fibromyalgia. Rheumatology international, 39(5), 781-791. https://doi.org/10.1007/s00296-019-04251-6
Batista, E. D. et al. (2016). Avaliação da ingestão alimentar e qualidade de vida de mulheres com fibromialgia. Revista Brasileira de Reumatologia. v.56, n.2, p.105-110.
CFF. (2020). Fibromialgia: sensibilidade, diagnóstico e responsabilidade no tratamento e acompanhamento do paciente. Disponível em: https://www.cff.org.br/noticia.php?id=5759. Conselho Federal de Farmácia.
Costa, A. V. F; Bezerra, L. C; Paula, J. A (2021). Use of psychotropic drugs in the treatment of fibromyalgia: a systematic review. Journal of Human Growth and Development, 31(2), 336-345.
Junior, J. & Almeida, M. (2018). The current treatment of fibromyalgia. Brazilian Journal of Pain, v. 1, n. 3, p. 255–262.
Kia, S. & Choy, E. (2017). Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology. Biomedicines.;5(2):20.
Marconi, M. & Lakatos, E. (2017). Fundamentos de metodologia científica. 8. ed. São Paulo: Atlas.
Marques, A. P. et al. (2017). A prevalência de fibromialgia: atualização da revisão de literatura. Revista Brasileira de Reumatismo, n.57, v.4, p. 356-363.
Morales, K. O. et. al. (2019). O uso da técnica manual shiatsu no alívio dos sintomas decorrentes da fibromialgia. Unisanta Health Science, 3(1), 1-17.
Oliveira Jr, J. O & Almeida, M. B. (2018). The current treatment of fibromyalgia. Br J Pain. 1(3):255-62.
Poluhal, R. L & Grossmann, E. A. (2018). pregabalina melhora os distúrbios do sono na fibromialgia? Br J Pain. São Paulo. abr-jun;1(2):163-6.
Portuguez, R. & Gallardo, P. (2017). Caracterización del dolor fibromiofascial, hipótesis etiológica, aplicación y efecto del tratamiento. Revista de la Sociedad Espanola del Dolor, v. 24, n. 4, p. 201–210.
Ribeiro, F. N (2016). Fibromialgia: o corpo, a mente e o estigma.
Souza, J. B. & Perissiotti, D. M. N. (2018). A prevalência da fibromialgia no Brasil – estudo de base populacional com dados secundários da pesquisa de prevalência de dor crônica brasileira. BrJP ; 1(4): 345-348, Oct.-Dec.
Sagy, I. V. et al. (2019). Safety and efficacy of medical cannabis in fibromyalgia. Journal of clinical medicine, 8(6), 1-12. https://doi.org/10.3390/jcm8060807
Tan, A. C; Aanieste, T; Champion, D. (2019). Chronic Widespread Pain and Fibromyalgia Syndrome: Life-Course Risk Markers in Young People. Pain Res Manag. 6584753.
Vilaça, M. M. O. et al. (2020). Novos medicamentos para o tratamento da fibromialgia. Research, Society and Development, [S. l.]. v. 9, n. 3, p. e24932308, 2020.
Wolfe F. et al. (2016). Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 46(3):319–329. doi: 10.1016/j.semarthrit.2016.08.012.
Ziani, M. M. et al. (2017). Efeitos da terapia manual sobre a dor em mulheres com fibromialgia: uma revisão de literatura. Ciência e Saúde, v.10, n.1, p. 48-55. 2017.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Emanuel Cadena da Silva; Erick Frota Gomes Figueiredo; Omero Martins Rodrigues Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
